SureTrader
Home > Boards > US OTC > Medical - Equipment >

Imagin Medical Inc. (IMEXF)

IMEXF RSS Feed
Add IMEXF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/18/2018 12:55:03 PM - Followers: 12 - Board type: Free - Posts Today: 0





 

 

Overview

 Imagin Medical is a medical imaging company
Imagin Medical will establish a new standard of care in the detection and removal of cancer using endoscopes by commercializing an advanced, proprietary and patented imaging technology
 Initially targeting bladder cancer 
 Thereafter expanding to all minimally invasive surgical (MIS) procedures where endoscopes are used
 

Benefits of Minimally Invasive Surgery (MIS)

• Performed using tiny holes or incisions (less muscle cut)
• Reduced pain, smaller / no scarring
• Quicker recovery, shorter hospital stay, less expensive
• Minimally invasive surgeries performed using endoscopes














 


Endoscopic Primer

• Endoscopic means “to look inside”
• Endoscope – a medical device with attached light used to look inside organs
• Endoscopy performed when other tools, such as an MRI, X-ray, or CT scan, are inappropriate
• Endoscopies commonly performed to diagnose cancer, take tissue samples for biopsies, and to remove cancer
• Different medical specialties use different types of endoscopes
• Cystoscopes, Bronchoscopes, Gastroscopes, Laparoscopes
   










 

Endoscopic Market
 
 $46B growing global endoscopy market
 $1B is spent annually in US alone on bladder cancer surveillance
 Bladder cancer is 3rd most common in men and 6th most common in US overall with recurrence rate of 40 – 70% making it the most expensive cancer to treat over the lifetime of a patient
 4 million estimated urology endoscopy procedures performed each year targeting bladder cancer
 Imagin’s disruptive imaging technology squarely addresses limitations in:
• Endoscopies targeting bladder cancer (cystoscopies)
• Endoscopies targeting many other cancers


 


 

Endoscope Limitations - White Light

• Current endoscopes use “white light” (or visible light) that has been the gold standard for decades
• Highly effective for detecting protruding cancerous tumors
• Limitations of white light:
• Tumors that are flat may look the same as normal tissue
• Not effective in visualizing the edges of the tumor
• Inability to illuminate tumors beneath skin surface


 

Endoscope Limitations - Blue Light

• Blue light cystoscopes (white light with blue filter) used with contrasting agents induce fluorescence and improve ability to detect flat cancers and visualize edges
• Drawbacks of existing blue light technology:
• Requires one hour for the agent to be absorbed by bladder
• Surgeon must manually “switch” between white light and blue light to see tumor area
• Repeated usage of imaging agent causes adverse side-effects (FDA limits use of contrast agents to one-time use per patient)
 

 
Disruptive Technology - Endoscopes with i/Blue Imaging System

• Significantly reduced prep time with bladder absorption in less than 15 minutes vs. one hour
• Optics 100,000 X more sensitive
• Simultaneous acquisition of differing images
• No switching back and forth
• Blends the white light and fluorescence images into one
• Enables the surgeon to better visualize and resect the cancer
• This advancement makes i/Blue technology practical, not only for the O.R. but also potentially for the physicians’ office
• Adapts seamlessly to most types of endoscopes on the market
 
Future Development - i/Vision Imaging System

• Incorporates multiple illumination sources in one system
• Accommodates the most commonly used fluorescing contrast agents, i.e., such as those based on the emission of Protoporphyrin IX (PpIX) and Indocyanine green (ICG)
• This instrument enables expansion into multiple endoscopic procedures such as laparoscopic (general and gynecology), colorectal, thoracic and gastroenterology procedures related to cancer and non-cancerous conditions
• Like i/Blue, blends two images into one, adapts to most endoscopes, and orders of magnitude more sensitive
 
Future Development - i/Red Imaging System

• Requires no contrasting agents - uses the fluorescence produced by the body and tumor itself
• Contrast between normal and cancer tissue is potentially related to difference in porphyrin content within the cells
• Dramatically expands the market to endoscopic procedures where imaging agents cannot be practically administered
• Like i/Blue, blends two images into one, adapts to most endoscopes, orders of magnitude more sensitive
 
Intellectual Property

• Underpinning company’s technology are three issued patents and two pending patent applications on technology related to near-infrared spectroscopic imaging for cancer and other medical applications obtained, under exclusive license, from Lawrence Livermore National Security, LLC
• Aim of licensing agreement is to commercialize the technology invented by Dr. Stavros Demos, a key advisor to the company


 
Product Development Roadmap


 
Why Invest in Imagin Medical?

• Key investment risks removed, high investment return potential
• Disruptive cutting edge imaging technology will dramatically reduce bladder cancer recurrence rates addressing $1B growing global market
• Limited R&D risks as concept is proven – this is an execution play
• Experienced medical device management team that has done it before
• Management in medical device field for over 30 years
• Worked together in previous companies
• High-margin product with strong clinical and economic advantages
• Commercial launch expected in 2018 with positive operating cash flows
• Strong acquisition market
• Most medical device companies grow by acquisition, not organically
• Company expected to have significant value with multiple liquidity options
 

 
Number of Shares Outstanding as at August 31, 2017:                50,068,739
 
Shares Subject to Resale Restrictions    
1) Shares subject to escrow (1,725,000 released every 6 months - Feb 9 & Aug 9) 5,175,000  
2) Performance shares 5,000,000  
Total Shares Subject to Resale Restrictions   10,175,000
Total Tradeable Float   39,893,739
Total Shares Outstanding   50,068,739

Number of Warrants Outstanding as at August 31, 2017:             25,005,064
 
Warrants Outstanding    
Feb 2016 Private Placement Strike @ 0.35 - expire Feb 9, 2018 7,007,413
Q4/2016 PP - Tranche 1 Strike @ 0.12 / 0.16 - expire Oct 20, 2018 5,111,300
Q4/2016 PP - Tranche 2 Strike @ 0.12 / 0.16 - expire Dec 9, 2018 3,980,565
Warrants from BSS acquisition Strike @ 0.15 - expire Feb 9, 2019 8,905,786
Total Warrants Outstanding   25,005,064

Number of Options Outstanding as at August 31, 2017:                3,350,000
 
 Management Options Outstanding    
Tranche 1 Strike @ 0.15 3,350,000
Total Options Outstanding   3,350,000
 
Various Company Links

Company Web Site
Corporate Presentation (10/2/2017)

CSE Web Site for Imagin Medical
SEDAR Web Site for Imagin Medical

Listing Statement CSE - February 16, 2016

Share Issuance - February 9, 2016
Share Issuance - August 22, 2016
Share Issuance - October 21, 2016
Share Issuance - December 13, 2016
Convertible Debt Issuance - March 3, 2017
Share Issuance - October 4, 2017

Option Grant - June 30, 2016
Option Grant - December 19, 2016
Option Grant - April 10, 2017

Information Circular - October 31, 2016

Monthly CSE Filings (CSE Form 7)
 
  2016 2017
January N/A Link
February Link Link
March Link Link
April Link Link
May Link Link
June Link Link
July Link Link
August Link Link
September Link  
October Link  
November Link  
December Link  

Financial Statements (FS) & Management Discussion and Analyses (MD&A)
 
      2015 2016 2017
Q2 Quarter Ended March 31 FS   Link Link
MD&A   Link Link
Q3 Quarter Ended June 30 FS   Link Link
MD&A   Link Link
Q4 Quarter Ended September 30 FS Link Link  
MD&A Link Link  
Q1 Quarter Ended December 31 FS Link Link  
MD&A Link Link  

 

 
SureTrader
IMEXF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#492   Yes,I don't have L2,but someone or something is jdemuss 01/18/18 12:55:03 PM
#491   Exactly. Who sells 46 shs of a 35c 7Card 01/18/18 12:48:38 PM
#490   It seems like it wants to run,but someone jdemuss 01/18/18 08:53:02 AM
#489   probably drop back to .32 12Rstirling 01/17/18 10:37:13 AM
#488   .356 high of day. Unlimited~OTC 01/17/18 09:46:02 AM
#487   You are right on target here. You called MSU 01/17/18 09:39:37 AM
#486   $IMEXF should have a good run tomorrow. Unlimited~OTC 01/16/18 08:08:53 PM
#485   Moving at a pace of .02 cents per MSU 01/16/18 04:49:20 PM
#484   Pull back won't happen until .75/.80 Getting walked up SO75 01/12/18 12:23:44 PM
#483   Possibly, but I am a buyer either way. I MSU 01/12/18 10:30:45 AM
#482   A pull back in the stock price is Neverending 01/12/18 07:30:18 AM
#481   2018 will be filled with news/progress/milestones hit. It's SO75 01/11/18 03:39:08 PM
#480   REVENUE projections will send this into multi dollars. MSU 01/11/18 03:27:05 PM
#479   Yes indeed. I like their Technology jdemuss 01/11/18 02:12:08 PM
#478   Nice! Keep em safe SO75 01/11/18 02:02:44 PM
#477   Added another 2300 shares. 7500 shares now owned. jdemuss 01/11/18 01:56:24 PM
#476   Fun comes at $5 SO75 01/11/18 01:47:22 PM
#475   Everybody having fun yet? MSU 01/11/18 01:46:03 PM
#474   52 week high! Let’s goooo JBowsNose 01/11/18 01:45:30 PM
#472   Fast lane to Revenue... MSU 01/11/18 01:42:13 PM
#470   Tht guy u were responding to,was just playing jdemuss 01/09/18 11:16:13 PM
#469   3 days in a row over 10% each MSU 01/09/18 04:39:26 PM
#468   I am finished responding to you. Go away please! MSU 01/09/18 04:33:54 PM
#466   again: what announcement? really could be anything hoyowasobo 01/09/18 04:02:35 PM
#465   Companies update announcement pushes breakout to hew highs. 7Card 01/09/18 11:44:05 AM
#464   Don't sound like the village idiot. 7Card 01/09/18 11:41:47 AM
#463   News is out today, please read and refrain MSU 01/09/18 11:27:29 AM
#462   lol. thats how u treat new ppl being hoyowasobo 01/09/18 11:24:22 AM
#461   Time will answer your question, not me I MSU 01/09/18 10:46:47 AM
#460   what announcement? hoyowasobo 01/09/18 10:30:08 AM
#459   All gaps closed, enjoy the ride! MSU 01/09/18 10:08:22 AM
#458   By the way up another 10% today. Is anybody listening? MSU 01/09/18 10:06:55 AM
#457   Last call, this will continue to be walked MSU 01/09/18 10:05:07 AM
#456   What have I been saying for a few MSU 01/09/18 10:02:42 AM
#455   One word future REVENUE. This is the future of MSU 01/09/18 10:02:05 AM
#454   Something's up gang. I think this is getting SO75 01/09/18 09:44:30 AM
#453   doin some research here. hoyowasobo 01/09/18 05:15:27 AM
#452   Up 10 % today a steady climb to MSU 01/08/18 06:07:14 PM
#451   Stockhouse is garbage altogether. Very rarely does anything SO75 01/08/18 04:49:04 PM
#450   Very good volume and price move in IME.c 7Card 01/08/18 04:23:24 PM
#449   That stockhouse message board is garbage eh. It Neverending 01/08/18 03:37:01 PM
#448   Based on future Market Cap buy out will MSU 01/05/18 05:29:25 PM
#447   Excellent article on the potential of Imagin Medical. 7Card 01/03/18 01:30:16 AM
#446   Found this Due Diligence report from these Equity Crytek89 01/02/18 10:00:43 AM
#445   Imagin Medical Research Study on Ten Patient's announced 11-29. 7Card 01/02/18 01:56:35 AM
#444   I have to be honest, this may be MSU 12/26/17 11:28:17 PM
#443   Walking it on up, this is going to MSU 12/26/17 11:59:49 AM
#442   Yeah this a no brained I cannot believe MSU 12/19/17 06:25:16 PM
#441   Buyout after FDA approval of i/Blue system and 7Card 12/17/17 08:13:52 PM
#440   Heard good things... MSU 12/13/17 10:02:27 PM
PostSubject